As of 29 Oct 2026, Novyra Pharmachem is loss-making on a trailing 12-month basis, with a net loss of ₹5.42 Cr, so it has no P/E ratio. The share price is ₹7.68, 54% below its 52-week high. It is a small-cap company with a market cap of ₹4.86 Cr; the shares fell 11% over the past year.
- ₹7.68
- ₹7.68
- ₹7.68
- ₹7.68
- 400
Health check
- ReturnsWeak
−11.1% over the past year.
- Price tagLoss-making
Earnings were negative over the last 12 months.
- Growthn/a
Not enough yearly results to measure.
- ProfitabilityNegative
ROE -166.1%.
- Balance sheetn/a
Balance sheet figures aren’t reported.
- Red flags3 to check
Loss-making over the last twelve months.
Key metrics
- Market cap
- ₹4.86 Cr
- Small cap
- P/E
- n/a
- Price to book
- 8.99
- Book value ₹0.85
- Dividend yield
- 0.00%
- ROE
- −166.1%
- Return on equity
- ROCE
- n/a
- Return on capital employed
- Debt to equity
- n/a
- Debt ₹0.00 Cr
- EPS (TTM)
- n/a
- OPM (TTM)
- −0.8%
- Net margin −89.8%
- Sales growth
- +12793.7%
- Latest quarter vs a year ago
- Profit growth
- n/a
- Year-ago quarter not reported
- Price to sales
- 0.81
- EV/EBITDA −0.9
Strengths and risks
Strengths
- Quarterly sales up 12793.7% on a year ago.
Risks to check
- Loss-making over the last twelve months.
- Return on equity is low at −166.1%.
- 54% below its 52-week high.
About Novyra Pharmachem
Novyra Pharmachem Limited cultivates, manufactures, and trades tea. It offers black tea, green tea, herbal infusion tea, and specialty tea. The company was formerly known as Bansisons Tea Industries Limited and changed its name to Novyra Pharmachem Limited in January 2026. The company was incorporated in 1987 and is based in Surat, India.
- Headquarters
- Surat
- Employees
- 3
- Sector
- Consumer Defensive
- ISIN
- INE856E01019
- Website
- novyrapharmachemltd.com
Price range
- Avg volume (3M)
- 74
- 1-year return
- minus 11.1%
- From 52-week high
- minus 53.6%
Peers
We couldn’t find listed peers for this company.
Quarterly results
This company doesn’t report these figures in a format we can read yet.
Profit & loss
This company doesn’t report these figures in a format we can read yet.
Forecast
Balance sheet
This company doesn’t report these figures in a format we can read yet.
Cash flow
This company doesn’t report these figures in a format we can read yet.
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.